Becton Dickinson and

Yahoo Finance • 14 hours ago

Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking Solventum (NYSE:SOLV)

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including Solventum (NYSE:SOLV) and its peers. The surgical equipment and consumables... Full story

Yahoo Finance • 4 days ago

Nike downgraded, IBM initiated: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Mizuho upgraded Shake Shack(SHAK) to O... Full story

Yahoo Finance • 5 days ago

For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System

New study findings published in the Journal of Clinical Medicine highlight the ease of use and comfort of BD PureWick® Female External Catheter can support a better night's rest FRANKLIN LAKES, N.J. , April 9, 2026 /PRNewswire/ -- BD (Bec... Full story

Yahoo Finance • 5 days ago

Nasdaq, S&P 500, Dow futures slip as hopes of U.S.-Iran resolution fade

[Lower Manhattan skyscrapers, New York City] Stock index futures were lower before the opening bell as hopes of a resolution to the U.S.-Iran conflict waned following warnings from President Donald Trump of a major escalation. Nasdaq 100... Full story

Yahoo Finance • 7 days ago

Australia Drug Delivery Devices Market Trends by Type of Product, Application Area and End-user - Forecast to 2035

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Australia Drug Delivery Devices Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product, Application Area and End-user" has been added to ResearchAndMarke... Full story

Yahoo Finance • 7 days ago

When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight

New HemoSphere Stream™ Module expands access to continuous, noninvasive arterial waveform data across compatible bedside monitors and broader care settings, giving more clinicians real-time insight into more patients. FRANKLIN LAKES, N.J.... Full story

Yahoo Finance • 15 days ago

3 Large-Cap Stocks with Questionable Fundamentals

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task. This dynam... Full story

Yahoo Finance • 20 days ago

Argus Lowers its Price Target on Becton, Dickinson and Company (BDX) to $180 from $230

Becton, Dickinson and Company (NYSE:BDX) is one of the 7 Most Undervalued Blue Chip Stocks to Invest In. On March 23, 2026, Argus lowered the price target on Becton, Dickinson and Company (NYSE:BDX) to $180 from $230 and maintained a Buy... Full story

Yahoo Finance • 23 days ago

Is Edwards Lifesciences Corporation (EW) A Good Stock To Buy Now?

Is EW a good stock to buy? We came across a bullish thesis on Edwards Lifesciences Corporation Torre Financial Newsletter’s Substack by Federico Torre. In this article, we will summarize the bulls’ thesis on EW. Edwards Lifesciences Corpor... Full story

Yahoo Finance • 27 days ago

3 Reasons BDX is Risky and 1 Stock to Buy Instead

Over the last six months, BD’s shares have sunk to $160.20, producing a disappointing 14.6% loss while the S&P 500 was flat. This was partly due to its softer quarterly results and might have investors contemplating their next move. Is no... Full story

Yahoo Finance • last month

3 Healthcare Stocks Walking a Fine Line

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have realized strong financial performance, and over the past six months, the industry’s 3.8%... Full story

Yahoo Finance • last month

Becton Dickinson Product Launches Aim To Deepen Recurring Hospital Revenue

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Becton Dickinson (NYSE:BDX) received FDA clearance for its Surgiphor 1000mL antimicrobial irrigation system, expanding... Full story

Yahoo Finance • last month

BDX Secures CE Mark for Revello Stent to Treat Iliac Artery Disease

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has received CE Mark approval in the European Union for its Revello Vascular Covered Stent. With this approval, BD is expanding its peripheral vascular p... Full story

Yahoo Finance • last month

Balloon Catheter Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo The Balloon Catheter market is projected to grow from $5.04 Billion in 2025 to $8.51 Billion by 2033, driven by a CAGR of 6.75%. This growth stems from increased cardiovascular disease cases and demand for minimally invasive... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: Viatris, Novo Nordisk, and Gilead Sciences in focus

Wall Street’s major market averages finished lower on Friday after the January wholesale inflation report came in hotter than expected. The blue-chip Dow was last lower by 1%, while the benchmark S&P 500 was -0.4%. At the same time, the t... Full story

Yahoo Finance • last month

Becton, Dickinson and Company (BDX): A Bull Case Theory

We came across a bullish thesis on Becton, Dickinson and Company on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on BDX. Becton, Dickinson and Company's share was trading at $176.66 as of February 26th. BDX’s t... Full story

Yahoo Finance • 2 months ago

Cancer Diagnostics Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts" report has been added to Rese... Full story

Yahoo Finance • 2 months ago

Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 Players - Sysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics

Company Logo By 2033, the Point of Care (POC) Diagnostics market is projected to reach a valuation of approximately US$ 105.22 billion, driven by an 8.60% CAGR from 2025. This robust growth is fueled by high demand for rapid and accessibl... Full story

Yahoo Finance • 2 months ago

Fill Finish Manufacturing Market Analysis Report 2026-2035: A $21+ Billion Market by 2030 with Johnson & Johnson, AbbVie, Thermo Fisher Scientific, BD & Co, Baxter, Lonza, and Catalent Leading

Company Logo Key market opportunities in the fill finish manufacturing sector include rising demand for cell and gene therapies, expansion in personalized medicine production, and increased outsourcing to CMOs. Growth is driven by innovat... Full story

Yahoo Finance • 2 months ago

First Pacific Advisors' Strategic Moves: Spotlight on Becton Dickinson & Co

This article first appeared on GuruFocus. Exploring the Latest 13F Filing and Key Investment Adjustments First Pacific Advisors (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, providing insights into... Full story